Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

BACKGROUND: The optimal dose of radioactive iodine (RAI) therapy for N1b papillary thyroid carcinoma (PTC) is controversial. We evaluated the clinical outcome of N1b PTC patients treated with either 100 or 150 mCi of RAI. METHODS: We retrospectively analyzed N1b PTC patients who underwent total thyr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Metab (Seoul)
Main Authors: Jin, Meihua, Ahn, Jonghwa, Lee, Yu-Mi, Sung, Tae-Yon, Kim, Won Gu, Kim, Tae Yong, Ryu, Jin-Sook, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Endocrine Society 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520585/
https://ncbi.nlm.nih.gov/pubmed/32981302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados